# Endourology Disease Group Excellence (EDGE) Consortium: Antibiotics (Abx) for Percutaneous Nephrolithotomy (PCNL) Part 2

> **NCT02829060** · NA · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 330 (actual)

## Conditions studied

- Nephrolithiasis
- Urinary Tract Infection (UTI)
- Sepsis

## Interventions

- **DRUG:** Nitrofurantoin 100 MG, 7d
- **DRUG:** Gentamicin, 5mg/kg
- **DRUG:** Ampicillin 2g
- **DRUG:** Nitrofurantoin 100 mg, 48 hrs
- **DRUG:** Gentamicin, 80 mg, 7d
- **DRUG:** Gentamicin, 80 mg, 48hr

## Key facts

- **NCT ID:** NCT02829060
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2025-01
- **Final completion:** 2025-03
- **Target enrollment:** 330 (ACTUAL)
- **Last updated:** 2025-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02829060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02829060, "Endourology Disease Group Excellence (EDGE) Consortium: Antibiotics (Abx) for Percutaneous Nephrolithotomy (PCNL) Part 2". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02829060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*